-
Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil
Mar 10, 2025, 14:00 PM -
Gut Microbiota and Inflammation in Patients Which Schizophrenia
Mar 10, 2025, 14:00 PM -
Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana
Mar 10, 2025, 14:00 PM -
Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis
Mar 10, 2025, 14:00 PM -
Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases
Mar 10, 2025, 14:00 PM -
Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies
Mar 10, 2025, 14:00 PM -
Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico
Mar 10, 2025, 14:00 PM -
Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil
Mar 10, 2025, 14:00 PM -
Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease
Mar 10, 2025, 14:00 PM -
Understanding Racial Differences in Emergency Room Visits for Patients with Lupus
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Indirect Costs Associated With Neovascular Age-Related Macular Degeneration (nAMD) in Colombia
Mar 10, 2025, 14:00 PM -
Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey
Mar 10, 2025, 14:00 PM